The role of mobile phones in improving vaccination rates in travelers.
暂无分享,去创建一个
C. Guinovart | Caterina Guinovart | A. Vilella | J. Bayas | Maria-Teresa Diaz | C. Díez | D. Simó | A. Muñoz | Javier Cerezo | Anna Vilella | Jose-Maria Bayas | Maria-Teresa Diaz | Consolación Diez | Dulcis Simó | Amparo Muñoz | Javier Cerezo
[1] Margaret Maglione,et al. Interventions That Increase Use of Adult Immunization and Cancer Screening Services , 2002, Annals of Internal Medicine.
[2] R H Behrens,et al. Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International airport. , 2006, Journal of travel medicine.
[3] S. Iwarson,et al. Excellent Booster Response 4-6 y after a Single Primary Dose of an Inactivated Hepatitis A Vaccine , 2002, Scandinavian journal of infectious diseases.
[4] R. Linkins,et al. The impact of computer-generated messages on childhood immunization coverage. , 2000, American journal of preventive medicine.
[5] N. Homedes. Do we know how to influence patients' behaviour? Tips to improve patients' adherence. , 1991, Family practice.
[6] T. Peters,et al. Daily regimen and compliance with treatment , 2002, BMJ : British Medical Journal.
[7] G. Wiedermann,et al. Compliance of austrian tourists with prophylactic measures , 1992, European Journal of Epidemiology.
[8] Ulrich Heininger,et al. A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine , 1998, Pediatrics.
[9] M. Ciocca. Clinical course and consequences of hepatitis A infection. , 2000, Vaccine.
[10] K. Dardick. Educating travelers about malaria: dealing with resistance and patient noncompliance. , 2002, Cleveland Clinic journal of medicine.
[11] B. Bell. Hepatitis A vaccine. , 2002, Seminars in pediatric infectious diseases.
[12] R. Vaughan,et al. Impact of appointment reminders on vaccination coverage at an urban clinic. , 2000, Pediatrics.
[13] R. Hornick,et al. A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and immunogenicity. , 2001, Vaccine.
[14] B. Bell,et al. Hepatitis A: how to match prevention strategies to changing epidemiology. , 2000, Vaccine.
[15] Y. Ni,et al. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults. , 2000, Vaccine.
[16] A. Safary,et al. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later , 1994, Journal of medical virology.
[17] J. Volmink,et al. Directly observed therapy and treatment adherence , 2000, The Lancet.
[18] M. Haine,et al. Van Damme A. , 1986 .
[19] A. Tärnvik,et al. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. , 1999, Vaccine.
[20] L E Rodewald,et al. Improving influenza vaccination rates in children with asthma: a test of a computerized reminder system and an analysis of factors predicting vaccination compliance. , 1992, Pediatrics.
[21] K. Kemper,et al. Do computer-generated reminder letters improve the rate of influenza immunization in an urban pediatric clinic? , 1993, American journal of diseases of children.
[22] P. Vandamme. Hepatitis A: how to match prevention strategies to changing epidemiology , 2000 .
[23] C. O’Haire,et al. The impact of outreach efforts in reaching underimmunized children in a Medicaid managed care practice. , 2000, Archives of pediatrics & adolescent medicine.
[24] G. Tognoni,et al. Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP. , 1998, Giornale italiano di cardiologia.
[25] B. Genton,et al. Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose. , 2000, Vaccine.
[26] J. O'grady,et al. Fulminant hepatitis in patients with chronic liver disease , 2000, Journal of viral hepatitis.
[27] R. Dal-Ré,et al. Compliance with immunization against hepatitis B. A pragmatic study in sexually transmitted disease clinics. , 1995, Vaccine.
[28] S. Collins,et al. How to improve the uptake of influenza vaccination in older persons at risk , 1999, Irish journal of medical science.
[29] M. Burnier,et al. Compliance to live oral Ty21a typhoid vaccine, and its effect on viability. , 2006, Journal of travel medicine.
[30] J. Keystone,et al. Vaccination of travelers against hepatitis A and B. , 1999, Journal of travel medicine.
[31] Dini,et al. The impact of computer-generated messages on childhood immunization coverage(2)(2) , 2000, American journal of preventive medicine.
[32] P. Hardy,et al. Association of panic disorder and panic attacks with hypertension. , 1999, American Journal of Medicine.
[33] I McDowell,et al. Use of reminders to increase compliance with tetanus booster vaccination. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[34] P. van Damme,et al. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use , 2002, Expert review of vaccines.
[35] M. Dietrich,et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. , 2002, Vaccine.
[36] J. Parry,et al. A collaborative case control study of sporadic hepatitis A in England. , 1995, Communicable disease report. CDR review.
[37] W. Hauck,et al. Antiretroviral Use and Pharmacy-Based Measurement of Adherence in Postpartum HIV-Infected Women , 2000, Medical care.
[38] M. Ferson,et al. Notification of infectious diseases by general practitioners: a quantitative and qualitative study , 2000, The Medical journal of Australia.
[39] J. Kazmierczak,et al. Hepatitis A infections in Wisconsin: trends in incidence and factors affecting surveillance, 1986-1995. , 1998, Wisconsin Medical Journal.
[40] P. Szilagyi,et al. Interventions aimed at improving immunization rates. , 2002, The Cochrane database of systematic reviews.
[41] F. Guillemin,et al. Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study. , 2000, Joint, bone, spine : revue du rhumatisme.
[42] B. Bloom,et al. Daily regimen and compliance with treatment , 2001, BMJ : British Medical Journal.
[43] B. Bloom. Continuation of initial antihypertensive medication after 1 year of therapy. , 1998, Clinical therapeutics.
[44] P. Hawe,et al. Randomised controlled trial of the use of a modified postal reminder card on the uptake of measles vaccination , 1998, Archives of disease in childhood.
[45] S. Benson,et al. Time to patient discontinuation of antihypertensive drugs in different classes. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[46] S. Iwarson. Are we giving too many doses of hepatitis A and B vaccines? , 2002, Vaccine.
[47] W. Wesołowski,et al. Diabetes care management: a managed care approach. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.
[48] C. Ericsson. Travel medicine: key to improved adult vaccination against Hepatitis A and B. , 2001, Journal of travel medicine.
[49] T. Lieu,et al. Effectiveness and Cost-effectiveness of Letters, Automated Telephone Messages, or Both for Underimmunized Children in a Health Maintenance Organization , 1998, Pediatrics.
[50] J. Gerberding,et al. Morbidity and Mortality Weekly Report Prevention of Hepatitis a through Active or Passive Immunization Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Coordinating Center for Health Information and Service Recommendations and Repo , 2022 .